Skip to main content
Caplight Logo









ATGC Co., Ltd.

ATGC Co., Ltd.

Private
SeoulHealthcare & Life Scienceshttps://atgcbio.com/

Last Round

Buyout/LBO

Jan 1, 2026

Est. Valuation

$59.3M

Total Funding Raised

$6.31M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ATGC Co., Ltd. is a biopharmaceutical company that develops novel botulinum toxin products and other therapeutic biologics for medical and aesthetic indications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceutical R&Dbotulinum toxinbotoxdrug licensingmedical aestheticsbiotechrecombinant proteinosteoarthritis therapeuticsGLP-1 analogopen innovationdrug development pipelineB2B pharmabiotherapeuticsclinical developmentmilestone payments

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ATGC Co., Ltd. Comparables

Compare ATGC Co., Ltd. with similar companies based on industry and business-model similarity.

ATGC Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
JETEMA Co., Ltd.
79%
Kanzen
78%
PharmaResearch
78%

ATGC Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBOJan 1, 2026
Series CJan 4, 2019

ATGC Co., Ltd. Investors

Notable investors and investment history

ATGC Co., Ltd. investors
InvestorRounds
KIWOOM Securities Co., Ltd.Series C
HB InvestmentVC Round, Series C
Korea Development BankVC Round
VIG PartnersBuyout/LBO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Led by VIG Partners.

  • Jan 4, 2019

    $6.3M round led by HB Investment.

ATGC Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

ATGC Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ATGC Co., Ltd.'s valuation, stock price, and market status.

Is ATGC Co., Ltd. a public or private company?

ATGC Co., Ltd. is a private company.

What is the current stock price of ATGC Co., Ltd.?

ATGC Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is ATGC Co., Ltd. worth (valuation)?

ATGC Co., Ltd.'s valuation is estimated at $59.3M based on funding round data.

Can I buy ATGC Co., Ltd. stock?

ATGC Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ATGC Co., Ltd.'s last funding round?

ATGC Co., Ltd.'s most recent funding round was Buyout/LBO on January 4, 2019.

Who are the main investors in ATGC Co., Ltd.?

Key investors in ATGC Co., Ltd. include VIG Partners.

Will ATGC Co., Ltd. IPO soon?

No public IPO plans have been announced for ATGC Co., Ltd..

How can I track ATGC Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ATGC Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range4
Year FoundedN/A
Last FundingJan 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?